We compared patients with CHD who had different HALP levels and found that age, gender, smoking, dyslipidemia, CKD, HB, ALB, lymphocyte, platelet, WBC, monocyte, treatment for anemia, anticonvulsants, and adrenal cortical steroids were all significantly different among the four HALP score groups (all P < 0.05). Here, NAT10 is linked to metabolic syndrome.